Circular RNA, once viewed as cell ‘junk,’ may influence Parkinson’s
Dopamine-making neurons — whose loss characterizes Parkinson’s disease — produce thousands of circular RNA molecules that, beyond their normal…
Articles by Marisa Wexler, MS
Study uncovers previously unknown role of parkin in dopamine signaling
The parkin enzyme — whose loss is a known genetic risk factor of Parkinson’s disease — not only helps…
Measuring eye movements may help track Parkinson’s progression
A platform developed by NeuraLight that uses machine learning to measure eye movements may help track the progression of…
Foundational AI tool identifies Parkinson’s by analyzing eye images
Researchers have developed a new tool, called RETFound, to analyze images of the eyes using artificial intelligence (AI). The scientists…
Gain Therapeutics cleared to start GT-02287 Phase 1 trial in Australia
An ethics committee in Australia has cleared Gain Therapeutics to start a Phase 1 clinical trial testing GT-02287, the…
MJFF grant supports therapies for PRKN-related disease
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $4.5 million grant to Nine Square…
Study: Clinicians must act to ease stigma of Parkinson’s disease
People with Parkinson’s disease commonly experience stigma associated with the disorder, and if clinicians are to provide proper care…
Magnetic brain stimulation eases symptoms in mouse model
A treatment that works to stimulate the brain using weak magnetic waves effectively eased symptoms in a mouse model of…
Addressing nonmotor symptoms of Parkinson’s empowers patients
People with Parkinson’s disease who have more severe nonmotor symptoms are less likely to feel empowered to manage their…
Variant in immune gene may help protect against neurological diseases
People with a specific variation in a gene that helps control the immune system are less likely to develop…